BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17094773)

  • 1. Budesonide treatment is associated with increased bile acid absorption in collagenous colitis.
    Bajor A; Kilander A; Gälman C; Rudling M; Ung KA
    Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1643-9. PubMed ID: 17094773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment.
    Münch A; Söderholm JD; Ost A; Ström M
    Am J Gastroenterol; 2009 Mar; 104(3):679-85. PubMed ID: 19209166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budesonide treatment and expression of inducible nitric oxide synthase mRNA in colonic mucosa in collagenous colitis.
    Bonderup OK; Hansen JB; Madsen P; Vestergaard V; Fallingborg J; Teglbjaerg PS
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1095-9. PubMed ID: 16957516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of bile acids in lymphocytic colitis.
    Ung KA; Kilander A; Willén R; Abrahamsson H
    Hepatogastroenterology; 2002; 49(44):432-7. PubMed ID: 11995467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial.
    Miehlke S; Madisch A; Bethke B; Morgner A; Kuhlisch E; Henker C; Vogel G; Andersen M; Meier E; Baretton G; Stolte M
    Gastroenterology; 2008 Nov; 135(5):1510-6. PubMed ID: 18926826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide.
    Miehlke S; Madisch A; Voss C; Morgner A; Heymer P; Kuhlisch E; Bethke B; Stolte M
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1115-9. PubMed ID: 16305725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic effects of acute terminal ileitis on uninflamed gut aggravate bile acid malabsorption.
    Stelzner M; Somasundaram S; Khakberdiev T
    J Surg Res; 2001 Aug; 99(2):359-64. PubMed ID: 11469911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis: budesonide treatment for collagenous colitis.
    Feyen B; Wall GC; Finnerty EP; DeWitt JE; Reyes RS
    Aliment Pharmacol Ther; 2004 Oct; 20(7):745-9. PubMed ID: 15379834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial.
    Bonderup OK; Hansen JB; Teglbjaerg PS; Christensen LA; Fallingborg JF
    Gut; 2009 Jan; 58(1):68-72. PubMed ID: 18669576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral pH-modified release budesonide for treatment of inflammatory bowel disease, collagenous and lymphocytic colitis.
    Gross V
    Expert Opin Pharmacother; 2008 May; 9(7):1257-65. PubMed ID: 18422482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low levels of bile acids increase bacterial uptake in colonic biopsies from patients with collagenous colitis in remission.
    Münch A; Söderholm JD; Ost A; Carlsson AH; Magnusson KE; Ström M
    Aliment Pharmacol Ther; 2011 Apr; 33(8):954-60. PubMed ID: 21366635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postprandial serum bile acid level and 75SeHCAT retention in diagnosis of bile acid malabsorption syndrome. A comparative study].
    Balzer K; Breuer N; Quebe-Fehling E
    Med Klin (Munich); 1993 Feb; 88 Suppl 1():23-8. PubMed ID: 8464395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of a selenium (75Se)-labelled bile acid for the investigation of terminal ileal function.
    Nyhlin H; Brydon G; Danielsson A; Westman S
    Hepatogastroenterology; 1984 Aug; 31(4):187-91. PubMed ID: 6479839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of bile acids and bile acid binding agents in patients with collagenous colitis.
    Ung KA; Gillberg R; Kilander A; Abrahamsson H
    Gut; 2000 Feb; 46(2):170-5. PubMed ID: 10644309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study.
    Ellegård L; Andersson H
    Eur J Clin Nutr; 2007 Aug; 61(8):938-45. PubMed ID: 17251929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of histopathological changes of ileum and colon in functional chronic diarrhea associated with bile acid malabsorption, assessed by SeHCAT test: a prospective study.
    Sciarretta G; Furno A; Morrone B; Malaguti P
    Am J Gastroenterol; 1994 Jul; 89(7):1058-61. PubMed ID: 8017365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption.
    Bajor A; Kilander A; Fae A; Gälman C; Jonsson O; Ohman L; Rudling M; Sjövall H; Stotzer PO; Ung KA
    Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):397-403. PubMed ID: 16538111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and inflammatory faecal markers in collagenous colitis.
    Wildt S; Nordgaard-Lassen I; Bendtsen F; Rumessen JJ
    Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):567-74. PubMed ID: 17556903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. After budesonide, what next for collagenous colitis?
    Pardi DS
    Gut; 2009 Jan; 58(1):3-4. PubMed ID: 19091826
    [No Abstract]   [Full Text] [Related]  

  • 20. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study.
    Miehlke S; Madisch A; Karimi D; Wonschik S; Kuhlisch E; Beckmann R; Morgner A; Mueller R; Greinwald R; Seitz G; Baretton G; Stolte M
    Gastroenterology; 2009 Jun; 136(7):2092-100. PubMed ID: 19303012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.